Puma Forecasts $202m-$206m in 2026 Nerlynx Net Product Revenue While Planning Alisertib Dose Escalation and New Lung2

Earnings Call Insights: Puma Biotechnology (PBYI) Q1 2026 Management view âToday, Puma reported total revenue for the first quarter of 2026 of $44.8 million,â said Founder, Chairman, President, CEO & Secretary Alan Auerbach, adding that âproduct revenue net was $42 millionâ and...</strong

Earnings Call Insights: Puma Biotechnology (PBYI) Q1 2026 Management view âToday, Puma reported total revenue for the first quarter of 2026 of $44.8 million,â said Founder, Chairman, President, CEO & Secretary Alan Auerbach, adding that âproduct revenue net was $42 millionâ and…

at results âwere impacted by approximately $7.9 million of inventory drawdown at Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed

This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank

Leave a Reply

Your email address will not be published. Required fields are marked *